Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products_英国招投标_中文版

• 首页 > 英国 > Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products

加载中...

Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products

发布时间	所属地区	所属机构	语言
2025年02月06日	--	--	英语 (English) 中文

抱歉，该信息暂无中文翻译信息，为您显示项目原文信息。

Published date: 6 February 2025

Open opportunity - This means that the contract is currently active, and the buying department is looking for potential suppliers to fulfil the contract.

Watch this notice Print this notice

Contract summary

Industry

Medical consumables - 33140000

Location of contract

SE1 8UG

Value of contract

£960,000,000 to £1,067,000,000

Procurement reference

tender_349185/1446962

Published date

6 February 2025

Closing date

10 March 2025

Closing time

3pm

Contract start date

28 November 2025

Contract end date

27 May 2027

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

What is an open procedure (above threshold)?

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

This Framework Agreement is for the supply of Insulin Pumps, Continuous Glucose Monitoring, Products Contributing to the Delivery of Hybrid Closed Loop Pathways and Associated Products.
This includes but not limited to tethered and patch insulin pumps, continuous glucose monitoring devices, products that contribute to the functionality of hybrid closed loop insulin delivery systems, and consumables.
Precise quantities are unknown. It is anticipated in the first year that spend will be approximately £215,015,000 - £245,017,000 GBP excluding VAT), however this is approximate only and may vary depending on requirements of bodies purchasing under the Framework. The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies from suppliers not appointed to the Framework at its sole discretion.

Estimated total value over the 4 year agreement is approximately £960,000,000 to £1,067,000,000 GBP (excluding VAT).

Applicants may bid for one, more than one or all of the Lots and Applicants should refer to the Invitation to Tender for more information in respect of this.

Under this Framework Agreement, there will be one method for supply - Direct Contract Goods.
For the Goods identified as Direct Contract Goods 1) NHS Supply Chain; 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body (for the avoidance of doubt including local authorities) and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the successful supplier for any of the Goods under the Framework Agreement.

Direct contracts placed under the Framework Agreement by parties other than NHS Supply Chain are between the party and the supplier, NHS Supply Chain will not be a party to those contracts.

The term of contracts formed under the Framework Agreement may continue beyond the end of the term of the Framework Agreement itself. NHS Supply Chain expects to provide successful Suppliers with the opportunity to offer additional savings to customers through the provision of discounted pricing, value added offerings and commitment initiatives.

NHS Supply Chain will share savings information in order to assist its customers with making informed procurement decisions.